Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Iron and Hepatic Carcinogenesis

Volume 18, Issue 5, 2013, pp. 391-407
DOI: 10.1615/CritRevOncog.2013007759
Get accessGet access

ABSTRACT

Iron is an essential co-factor for life; however, a physiologically optimal balance is critical. Too much or too little iron can have detrimental effects on human health. In this article, we explore the relationships between iron and hepatocellular carcinoma (HCC). Iron can act as a modulating co-factor in a range of chronic liver diseases and can accelerate the development of liver injury, fibrosis, cirrhosis, and ultimately HCC. Iron can, however, also act as a sole factor in the causation of liver cirrhosis and HCC in individuals with hereditary hemochromatosis (HH). We overview the regulation of normal iron metabolism and the role of iron in wound healing and associated cell types as well as in pathophysiologies that predispose to HCC. We review how these injury processes are inextricably linked, providing a mechanistic basis for understanding how iron and hepatic injury potentially result in HCC.

CITED BY
  1. Waldvogel-Abramovski Sophie, Waeber Gérard, Gassner Christoph, Buser Andreas, Frey Beat M., Favrat Bernard, Tissot Jean-Daniel, Iron and transfusion medicine, Blood Reviews, 27, 6, 2013. Crossref

  2. Cho Hyo Jung, Kim Soon Sun, Ahn Seun Joo, Park Joo Han, Kim Dong Joon, Kim Young Bae, Cho Sung Won, Cheong Jae Youn, Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B, Clinical and Molecular Hepatology, 20, 4, 2014. Crossref

  3. Noritake Hidenao, Kobayashi Yoshimasa, Ooba Yukimasa, Kitsugi Kensuke, Shimoyama Shin, Yamazaki Satoru, Chida Takeshi, Watanabe Shinya, Kawata Kazuhito, Suda Takafumi, Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients, ISRN Hepatology, 2014, 2014. Crossref

  4. Luo Xian Fu, Xie Xue Qian, Cheng Shu, Yang Yi, Yan Jing, Zhang Huan, Chai Wei Min, Schmidt Bernhard, Yan Fu Hua, Dual-Energy CT for Patients Suspected of Having Liver Iron Overload: Can Virtual Iron Content Imaging Accurately Quantify Liver Iron Content?, Radiology, 277, 1, 2015. Crossref

  5. Funakoshi Natalie, Chaze Iphigénie, Alary Anne-Sophie, Tachon Gaëlle, Cunat Séverine, Giansily-Blaizot Muriel, Bismuth Michael, Larrey Dominique, Pageaux Georges-Philippe, Schved Jean-François, Donnadieu-Rigole Hélène, Blanc Pierre, Aguilar-Martinez Patricia, The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients, Liver International, 36, 5, 2016. Crossref

  6. Urano Shinichi, Ohara Toshiaki, Noma Kazuhiro, Katsube Ryoichi, Ninomiya Takayuki, Tomono Yasuko, Tazawa Hiroshi, Kagawa Shunsuke, Shirakawa Yasuhiro, Kimura Fumiaki, Nouso Kazuhiro, Matsukawa Akihiro, Yamamoto Kazuhide, Fujiwara Toshiyoshi, Iron depletion enhances the effect of sorafenib in hepatocarcinoma, Cancer Biology & Therapy, 17, 6, 2016. Crossref

  7. Zimmermann Arthur, Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations, in Tumors and Tumor-Like Lesions of the Hepatobiliary Tract, 2017. Crossref

  8. Raggi Chiara, Gammella Elena, Correnti Margherita, Buratti Paolo, Forti Elisa, Andersen Jesper B, Alpini Gianfranco, Glaser Shannon, Alvaro Domenico, Invernizzi Pietro, Cairo Gaetano, Recalcati Stefania, Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells, Scientific Reports, 7, 1, 2017. Crossref

  9. Tarocchi M., Galli A., Oxidative Stress as a Mechanism for Hepatocellular Carcinoma, in Liver Pathophysiology, 2017. Crossref

  10. ZHANG ZEYU, LIU DAN, YI BO, LIAO ZHANGPING, TANG LEI, YIN DONG, HE MING, Taurine supplementation reduces oxidative stress and protects the liver in an iron-overload murine model, Molecular Medicine Reports, 10, 5, 2014. Crossref

  11. Köhn-Gaone Julia, Gogoi-Tiwari Jully, Ramm Grant A., Olynyk John K., Tirnitz-Parker Janina E. E., The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis, American Journal of Physiology-Gastrointestinal and Liver Physiology, 310, 3, 2016. Crossref

  12. Silva Inês, Rausch Vanessa, Seitz Helmut-Karl, Mueller Sebastian, Does Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?, Cancers, 9, 12, 2017. Crossref

  13. Abadia Andres F., Grant Katharine L., Carey Kathleen E., Bolch Wesley E., Morin Richard L., Spatial Distribution of Iron Within the Normal Human Liver Using Dual-Source Dual-Energy CT Imaging, Investigative Radiology, 52, 11, 2017. Crossref

  14. Surve Dipti, Idowu Michael O., Molecular Biology Basics in the “Omics” Era: Cancer Pathology, in Molecular Oncology Testing for Solid Tumors, 2015. Crossref

  15. Caviglia Gian P., Olivero Antonella, Rosso Chiara, Bosco Caterina, Ribaldone Davide G., Fagoonee Sharmila, Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma, Minerva Biotecnologica, 30, 3, 2018. Crossref

  16. Gabr Sami A., Gabr Nada S., Elsaed Wael M., Protective Activity of Taurine and Molecular Fibrogenesis in Iron Overloaded Hepatic Tissues, International Journal of Pharmacology, 15, 3, 2019. Crossref

  17. Zimmermann Arthur, Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations, in Tumors and Tumor-Like Lesions of the Hepatobiliary Tract, 2016. Crossref

  18. Adachi Makiko, Kai Keita, Yamaji Koutaro, Ide Takao, Noshiro Hirokazu, Kawaguchi Atsushi, Aishima Shinichi, Transferrin receptor 1 overexpression is associated with tumour de‐differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma, Histopathology, 75, 1, 2019. Crossref

  19. Kindrat Iryna, Tryndyak Volodymyr, de Conti Aline, Shpyleva Svitlana, Mudalige Thilak K., Kobets Tetyana, Erstenyuk Anna M., Beland Frederick A., Pogribny Igor P., MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis, Oncotarget, 7, 2, 2016. Crossref

  20. Xiao Chong, Fu Xi, Wang Yuting, Liu Hong, Jiang Yifang, Zhao Ziyi, You Fengming, Papaccio Gianpaolo, Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation, PLOS ONE, 15, 12, 2020. Crossref

  21. Patel Vishal, Joharapurkar Amit, Kshirsagar Samadhan, Patel Maulik, Patel Hiren, Savsani Hardikkumar, Jain Mukul, Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice, Drug Research, 71, 09, 2021. Crossref

  22. Xiang-tao Pan, Expression of Hepcidin and Neogenin in colorectal cancer, Open Medicine, 12, 1, 2017. Crossref

  23. Han Jin-Yi, Ahn Keun Soo, Baek Won-Ki, Suh Seong-Il, Kim Yong Hoon, Kim Tae-Seok, Kang Koo Jeong, Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease, Surgical Oncology, 34, 2020. Crossref

  24. Mueller Sebastian, Chen Cheng, Mueller Johannes, Wang Shijin, Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis, Journal of Translational Internal Medicine, 10, 2, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain